·Î±×ÀÎ Àüü´º½º¿ÀÇǴϾðEnglishÆÊ ¾ÆÄ«µ¥¹ÌÆʽºÅ¸Å¬·´TVÆʵµ¶ó¸®Äí¸£Æ®DPºÎµ¿»êÀλ絿Á¤Event & Çмú¼¼¹Ì³ªµ¶ÀÚÁ¦º¸
°Ë»ö ä¿ëÁ¤º¸ Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇؿܾà´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇÏ°í´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇÏ°í´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Çؿܾà´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø Çؿܾà´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ... ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇؿܾà´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇÏ°í´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇÏ°í´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °ü·Ã±â»ç · Çؿܾà´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø Çؿܾà´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ... ÇØÅÂhtb ÀÍ»ê°øÀå °ü¸®¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Representative (Á¾º´ ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â ¸¶ÄÉÆà ¾à»ç, Àü¹®¿¬±¸¿ä¿ø ¸ðÁý ¹Ù·Î°¡±â Æĸ¶¿¡¼¾½Ã¾ÆÄÚ¸®¾Æ MSL ½Å±Ô ä¿ë ¹Ù·Î°¡±â Medical Representative (Ŭ¸®´Ð ¿µ¾÷ - °è¾àÁ÷) ¹Ù·Î°¡±â Senior Regulatory Science Specialist(1Yr) ¹Ù·Î°¡±â Junior Marketing Manager ä¿ë ¹Ù·Î°¡±â PMS Lead (Fixed-term) ¹Ù·Î°¡±â (ÀüºÏ(ÀüÁÖ °ÅÁÖ)) ¿µ¾÷ºÎ ½ÅÀÔ/°æ·ÂÁ÷(ÁÖÀÓ~´ë¸®±Þ) ¸ðÁý ¹Ù·Î°¡±â ÀÓ»óÆÀ PM °æ·Â(2³â ÀÌ»ó) ä¿ë ¹Ù·Î°¡±â Á¶¾ÆÁ¦¾à Ç°Áú°ü¸®¾à»ç °æ·Â ä¿ë ¹Ù·Î°¡±â [À¯¸í¿Ü±¹°èÁ¦¾à»ç] ½ÅÀÔ¾à»ç & °æ·Â MSL µî ´Ù¼ö ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Medical Scientific Affair ä¿ë(À°¾ÆÈÞÁ÷´ëü_±â°£Á¦) ¹Ù·Î°¡±â °³¹ß±âȹÆÀ BD °æ·Â(7³â ÀÌ»ó)ä¿ë ¹Ù·Î°¡±â ´õÇö´ë ¼¿ï ÇÍŸ¹Î ¾à±¹ ÆÄÆ® ¾à»ç ä¿ë ¹Ù·Î°¡±â Medical Science Liaison (Oncology) / Head of Market Access & External Affairs / MR(¿µ¾÷ºÎ) ä¿ë ¹Ù·Î°¡±â Á¦¾à¾à»çä¿ë ¹Ù·Î°¡±â ÀÓ»óÆÀ¿ø(Á¤±ÔÁ÷), RA/QAÆÀ¿ø,PVÆÀ¿ø(°è¾àÁ÷) ä¿ë ¹Ù·Î°¡±â QC, QA, Medical Affairs, MR(º´¿ø¿µ¾÷) ä¿ë ¹Ù·Î°¡±â (Sr.) Local Research Specialist ¹Ù·Î°¡±â Sr. Regulatory Affairs Specialist (18 months contract) ¹Ù·Î°¡±â Çѱ¹¿¡ÀÚÀÌ Sr. MSL Associate ä¿ë(Á¤±ÔÁ÷) ¹Ù·Î°¡±â ¼¿Æ®¸®¿Â 2025³â 1Â÷ ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â Ç°Áú±×·ìÀå(ÀÌ»ç±Þ), °ü¸®¾à»ç ¸ðÁý ¹Ù·Î°¡±â ¢ß¼¿Æ®¸®¿ÂÁ¦¾à ½ÅÀÔ/°æ·Â ¼ö½Ãä¿ë ¹Ù·Î°¡±â 0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö
ä¿ëÁ¤º¸ Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% ±â»çÀÔ·Â : 24.07.04 14:15:02 0 °¡ ÇÃÄ£Ãß°¡ ±¹½Ã¿ø, Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ¹ßÇ¥ 179¸í ÀÀ½ÃÇØ 83¸í ÇÕ°Ý...À۳⠴ëºñ ÇÕ°Ý·ü 20% »ó½Â [µ¥Àϸ®ÆÊ=Á¤ÈïÁØ ±âÀÚ] ÇØ¿Ü ¾à´ë Ãâ½Å 83¸íÀÌ ³»³â ¾à»ç±¹°¡°í½Ã ÀÀ½Ã ÀÚ°ÝÀ» ¾ò¾ú´Ù. ±¹½Ã¿øÀÌ ¿À´Ã(4ÀÏ) °øÁöÇÑ Á¦5ȸ ¾à»ç¿¹ºñ½ÃÇè °á°ú¿¡ µû¸£¸é ÇÕ°ÝÀÚ´Â ÀÀ½ÃÀÚ 179¸í Áß 83¸í·Î 46.4%ÀÇ ÇÕ°Ý·üÀÌ´Ù. ¡ãÇؿܾà´ë Ãâ½Å 179¸í Áß 83¸íÀÌ ÇÕ°ÝÇß´Ù. ÇÕ°Ý·üÀº 46.4%´Ù. ¸Å³â ¿Ï¸¸ÇÏ°Ô »ó½ÂÇÏ´ø ÇÕ°Ý·üÀº ¿ÃÇØ ±ÞÁõÇß´Ù. 1ȸ ¿¹ºñ½ÃÇè¿¡¼ 5.8%¿´´ø ÇÕ°Ý·üÀº ¼¼È÷ »ó½ÂÇØ ÀÛ³â 4ȸ ½ÃÇè¿¡¼´Â 27.2%¸¦ ±â·ÏÇß´Ù. ¿ÃÇØ ÀÀ½ÃÀÚ°¡ ´Ã¾î³µ°í, ÇÕ°Ý·üÀº À۳⠴ëºñ ¾à 20% °¡±îÀÌ »ó½ÂÇÏ¸é¼ ÇÕ°Ý»ýÀÌ ´ë°Å ´Ã¾ú´Ù. ¸Å³â ¾à»ç¿¹ºñ½ÃÇè ÇÕ°ÝÀÚ Áß ±Ø¼Ò¼ö¸¦ Á¦¿ÜÇÏ°í´Â ¾à»ç±¹½Ã¿¡ ÇÕ°ÝÇÏ´Â Ãß¼¼´Ù. 1~3ȸÂ÷¿¡¼´Â 1¸íÀ» Á¦¿ÜÇÏ°í´Â ±¹½Ã ÇÕ°ÝÇß´Ù. X AD Â¥¸Ô´Â Àº±³»ê Ãâ½Ã! À̺¥Æ®Âü¿© ¡æ Á¤ÈïÁØ ±âÀÚ(jhj@dailypharm.com) ±ÛÀÚÅ©±â ¼³Á¤ °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç °¡³ª´Ù¶ó¸¶¹Ù»ç
°ü·Ã±â»ç · Çؿܾà´ë Ãâ½Å ¾à»ç ´õ ´Ã¾î³´Ù...¿¹ºñ½ÃÇè 196¸í... · ±Þ°¨Çß´ø Çؿܾà´ë Ãâ½Å ¾à»ç, 4³â »õ 8¹è Áõ°¡ · Çʸ®ÇÉÀº ÀÌÁ¨ ¿¾¸»...¿Ü±¹ ¾à´ë ±¹½ÃÇÕ°Ý ¹Ì±¹ÀÌ ...
0/300 ÀÌ¿ë¾à°ü | °³ÀÎÁ¤º¸ Ãë±Þ¹æħ | ¹ýÀû°íÁö Copyright ¨Ï Dailypharm 1999-2025,All rights reserved. ¸ÞÀϺ¸³»±â ±â»çÁ¦¸ñ : Çؿܾà´ë Ãâ½Å 83¸í, ¾à»ç±¹½Ã º»´Ù...¿¹ºñ½ÃÇè ÇÕ°Ý·ü 46% URLº¹»ç ¸ÞÀÏ Æ®À§ÅÍ ÆäÀ̽ººÏ Ä«Ä«¿À½ºÅ丮 Ä«Ä«¿ÀÅå ¹êµå ³×À̹ö